Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. CREON 25 000 U, microgranules gastrorésistants en gélules (boîte de 60)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
  • Date 09 May 2001
  • Documents : 1
  • History
Listen Listen
Add to my selection
    Quote this publication
    Share
    Share on
    Facebook share - facebook.com - new window
    Tweeter share - Partager sur Twitter - twitter.com - new window
    LinkedIn share - linkedin.com - new window
    Print

    CREON 25 000 U, microgranules gastrorésistants en gélules (boîte de 60)

    Opinions on drugs - Posted on May 09 2001 - Updated on Aug 14 2006

    Documents

    • Avis_médicament_ct010079.pdf Xvox

    Contact Us

    Évaluation des médicaments
    • Contact Us
    All our publications
      Congenital, genetic and rare diseases Drug therapy Paediatrics Pancreatic and biliary tract diseases Pulmonary and pleural diseases

    Follow us :

    • Twitter (nouvelle fenêtre)
    • Facebook (nouvelle fenêtre)
    • Youtube (nouvelle fenêtre)
    • LinkedIn (nouvelle fenêtre)
    Haute Autorité de Santé
    Advancing quality in the fields of health and social care services
    • Eunetha.eu
    • Pasq.eu
    • All our publications by topic and type
    • Opinions on medicines
    • Opinions on medical devices
    • INAHTA briefs
    • Français
    • English
    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
    U1btzxXM8p9ushgq